Cardiovascular · 2018

FDA-cleared AI devices for cardiovascular 2018

2018 has 10 cardiovascular AI devices, 42.9% more than 2017 (7). That is 6.5% of the 154 cardiovascular devices on the FDA list, and 15.4% of all AI-device decisions dated 2018. The most active were Cardio-Phoenix Inc. (1), CathWorks Ltd (1), Edwards Lifesciences, LLC (1). The newest is FFRangio System from CathWorks Ltd, decided on December 19, 2018.

102018 devices
10Companies
15.4%Of all 2018 AI devices
6.5%Of all cardiovascular

By month

Jan: 1Feb: 0Mar: 1Apr: 1May: 1Jun: 0Jul: 0Aug: 1Sep: 1Oct: 0Nov: 1Dec: 3
JanFebMarAprMayJunJulAugSepOctNovDec
Cardiovascular AI devices by month in 2018: Jan 1, Feb 0, Mar 1, Apr 1, May 1, Jun 0, Jul 0, Aug 1, Sep 1, Oct 0, Nov 1, Dec 3

All 10 devices

Frequently asked questions

How many FDA-cleared AI cardiovascular devices were there in 2018?

10 AI-enabled cardiovascular devices have a final decision dated 2018, from 10 companies.

How does 2018 compare with 2017 for AI cardiovascular devices?

2018 has 10 cardiovascular AI devices, 42.9% more than 2017 (7).

Which companies cleared the most AI cardiovascular devices in 2018?

Cardio-Phoenix Inc. (1), CathWorks Ltd (1), Edwards Lifesciences, LLC (1).

What was the most recent AI cardiovascular device in 2018?

FFRangio System from CathWorks Ltd (K182149), decided on December 19, 2018. Product code QEK.

Which product codes were most common for AI cardiovascular devices in 2018?

DQK (Computer, Diagnostic, Programmable): 2; MWI (Monitor, Physiological, Patient (Without Arrhythmia Detection Or Alarms)): 2; DPS (Electrocardiograph): 1.

Cite as: AI Device Radar, “FDA-cleared AI devices for cardiovascular 2018,” https://ai-device-radar.vercel.app/specialty/cardiovascular/2018 (FDA list through 2026-06-29).